证券代码：688289 证券简称：圣湘生物 公告编号：2025-049 圣湘生物科技股份有限公司 关于 2025 年限制性股票激励计划内幕信息知情 人买卖公司股票情况的自查报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 圣湘生物科技股份有限公司（以下简称"公司"）于 2025 年 7 月 10 日召开了第二 届董事会 2025 年第八次临时会议和第二届监事会 2025 年第五次临时会议，审议通过 了《圣湘生物科技股份有限公司关于 <公司 ensp="ensp" 年限制性股票激励计划="年限制性股票激励计 划" 草案="草案"> 及 （一）核查对象为本激励计划的内幕信息知情人（以下简称"核查对象"）。 （二）本激励计划的内幕信息知情人均填报了《内幕信息知情人登记表》。 其摘要的议案》等议案，并于 2025 年 7 月 12 日在上海证券交易所网站（www.sse.com.cn） 披露了相关公告。 根据《上市公司股权激励管理办法》（以下简称"《管理办法》"）、《上市公司信 息披露管理办法》及其他公司内部制度的有关规定，公 ...

（文章来源：证券日报） 证券日报网讯 7月29日晚间，圣湘生物发布公告称，同意选举任小梅女士为公司第三届董事会职工代表 董事。 ...

（文章来源：证券日报） 证券日报网讯 7月29日晚间，圣湘生物发布公告称，公司2025年第三次临时股东会审议通过了《关于及 其摘要的议案》等多项议案。 ...

证券代码：688289 证券简称：圣湘生物 公告编号：2025-049 圣湘生物科技股份有限公司 关于 2025 年限制性股票激励计划内幕信息知情 人买卖公司股票情况的自查报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 圣湘生物科技股份有限公司（以下简称"公司"）于 2025 年 7 月 10 日召开了第二 届董事会 2025 年第八次临时会议和第二届监事会 2025 年第五次临时会议，审议通过 了《圣湘生物科技股份有限公司关于<公司 2025 年限制性股票激励计划（草案）>及 其摘要的议案》等议案，并于 2025 年 7 月 12 日在上海证券交易所网站（www.sse.com.cn） 披露了相关公告。 根据《上市公司股权激励管理办法》（以下简称"《管理办法》"）、《上市公司信 息披露管理办法》及其他公司内部制度的有关规定，公司对 2025 年限制性股票激励 计划（以下简称"本激励计划"）采取了充分必要的保密措施，对本激励计划的内幕信 息知情人进行了登记。根据《管理办法》《上海证券交易所科创板股票上市规则》《科 创 ...

圣湘生物科技股份有限公司（以下简称"公司"或"圣湘生物"）第二届董事会 任期已届满，根据《中华人民共和国公司法》（以下简称"《公司法》"）《上海证券交 易所科创板股票上市规则》《上海证券交易所科创板上市公司自律监管指引第 1 号—— 规范运作》等法律、法规、规范性文件以及《公司章程》等有关规定，公司开展了董 事会换届选举工作。公司第三届董事会由 11 名董事组成，其中职工代表董事 1 名， 由公司职工代表大会选举产生。 证券代码：688289 证券简称：圣湘生物 公告编号：2025-050 圣湘生物科技股份有限公司 关于选举第三届董事会职工代表董事的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 2025 年 7 月 30 日 附件：职工代表董事简历 任小梅女士，1987 年 8 月出生，中国国籍，无境外永久居留权，英国牛津大学生 物化学博士。湖南省"百人计划"专家，湖南省高层次聚集人才工程专家。2016 年加入 圣湘生物，历任公司研发项目经理、研发项目总监、呼吸道产线总监等职务，现任圣 湘生物生命科学研究院副院长。 ...

证券代码：688289 证券简称：圣湘生物 公告编号：2025-051 圣湘生物科技股份有限公司 2025年第三次临时股东会决议公告 （一） 股东会召开的时间：2025 年 7 月 29 日 （二） 股东会召开的地点：上海市闵行区华西路 680 号（圣湘生物上海产业园） （三） 出席会议的普通股股东、特别表决权股东、恢复表决权的优先股股东及 其持有表决权数量的情况： | 1、出席会议的股东和代理人人数 | 181 | | --- | --- | | 普通股股东人数 | 181 | | 2、出席会议的股东所持有的表决权数量 | 255,198,546 | | 普通股股东所持有表决权数量 | 255,198,546 | | 3、出席会议的股东所持有表决权数量占公司表决权数量的比 | 44.45 | | 例（%） | | | 普通股股东所持有表决权数量占公司表决权数量的比例（%） | 44.45 | 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 本次会议是否有被否决议案：无 一、 会议召开和出席情况 （四） 表决 ...

关于 圣湘生物科技股份有限公司 2025年第三次临时股东大会的 法律意见书 致：圣湘生物科技股份有限公司 湖南启元律师事务所（以下简称"本所"）接受圣湘生物科技股份有限公司 （以下简称"公司"）的委托，指派本所律师出席了公司 2025 年第三次临时股东 大会（以下简称"本次股东大会"），对本次股东大会的召集和召开程序、出席 会议人员及召集人的资格、表决程序和表决结果的合法有效性进行现场律师见证， 并发表本法律意见。 本次股东大会采取现场投票与网络投票相结合的方式，公司将通过上海证券 交易所交易系统和互联网投票系统向公司股东提供网络形式的投票平台，公司股 东可以在网络投票时间内通过上述系统对议案行使表决权。 现场投票：本次股东大会现场会议于 2025 年 7 月 29 日 14 点 30 分在上海市 闵行区华西路 680 号（圣湘生物上海产业园）召开。会议由董事长戴立忠先生主 持。 （一）在本法律意见书中，本所仅对本次股东大会的召集和召开程序、出席 会议人员的资格、召集人资格、会议表决程序以及表决结果是否符合《公司法》 《股东会规则》以及《公司章程》的规定发表意见，并不对本次股东大会所审议 的提案内容以及这些提 ...

Market Overview - The A-share market shows a mixed performance with the Shanghai Composite Index closing at 3597.94, up 0.12%, while the Shenzhen Component Index rose by 0.44% to 11217.58 [1][2] - The total market capitalization of the Shanghai Composite Index is 694,091 million, with a price-to-earnings (PE) ratio of 12.85 and a price-to-book (PB) ratio of 1.34 [2] Financial Insights - The report highlights a rebound in the market, particularly in the computing hardware sector, which saw significant gains [3][5] - The overall market saw 2,781 companies rise and 2,436 decline, with a total trading volume of 17,661.5 billion, a decrease of 493.01 billion from the previous trading day [7] Industry Dynamics - Tencent launched the "Mixed Yuan 3D World Model" and the "Tairos" platform, showcasing AI applications [23][24] - The Shanghai Municipal Drug Administration issued a priority approval procedure for certain medical devices, aiming to expedite the registration process for innovative products [26] - Alibaba unveiled its first self-developed Quark AI glasses, integrating payment features with Alipay [28] Company Developments - Heng Rui Medicine (600276.SH) signed a collaboration and licensing agreement with GSK, involving a potential total payment of approximately 12 billion USD for the development and commercialization of multiple projects [30][31] - Saint Shine (688289.SH) received medical device registration certificates for two products, enhancing its portfolio in pharmacogenomics [33][34] Economic Policies - The National Childcare Subsidy Program was announced, providing annual subsidies of 3,600 yuan per child for families with children under three years old starting January 1, 2025 [14] - The People's Bank of China conducted a 4,958 billion yuan reverse repurchase operation, injecting liquidity into the market [16] Regional Economic Updates - In Hunan Province, 50 key projects in the electronic information manufacturing sector completed investments totaling 15.18 billion yuan, with significant progress in major projects [35][36]

Group 1 - Changhua Group received a product purchase contract for carbon-ceramic brake discs, with a total sales amount expected to exceed 100 million yuan over a 5-year lifecycle, starting mass production in Q2 2026 [1] - Zhongke Environmental reported a net profit of 196 million yuan for the first half of 2025, a year-on-year increase of 19.83%, with revenue of 848 million yuan, up 4.48% [1] - WuXi AppTec's net profit for the first half of 2025 grew by 101.92% to 8.561 billion yuan, with revenue of 20.799 billion yuan, a 20.64% increase [1][2] - Sujiao Technology's net profit decreased by 39.54% to 95.39 million yuan, with revenue down 13.75% to 1.776 billion yuan [1] - Jucheng Co. reported a net profit of 205 million yuan, a significant increase of 43.5%, with revenue of 575 million yuan, up 11.69% [1] Group 2 - Sanxiang New Materials plans to invest up to 300 million yuan in a zirconium-hafnium separation project, with a production capacity of 20,000 tons [1] - Koweil received government subsidies totaling 4.9752 million yuan, accounting for 10.14% of its audited net profit [1] - Xinhua Medical obtained two Class II medical device registration certificates for digital X-ray machines [1] - Huanxu Electronics reported a net profit of 638 million yuan, down 18.66%, with total revenue of 27.214 billion yuan, a slight decrease of 0.63% [1] - Zhenhua Co.'s general manager was fined 100,000 yuan for violations related to stock trading by his child [1] Group 3 - Huafeng Aluminum signed a raw material purchase contract worth over 7.2 billion yuan for a five-year period, committing to purchase at least 360,000 tons of raw materials [1] - Hongxin Technology received a project designation letter and procurement contract from a major domestic automotive brand [1] - Meihe Co. obtained a patent for a device used in supporting automatic flipping on conveyor lines in the automotive manufacturing sector [1] - Xin Hongye's subsidiary won a bid for an electrical penetration project worth 40.8831 million yuan [1] - Fuan Pharmaceutical's subsidiary received a drug registration certificate for an injection used in liver disease treatment [1] Group 4 - Tianzhong Precision's subsidiary's bankruptcy liquidation application was accepted by the court due to insufficient assets to cover debts [1] - Zhonghong Medical's subsidiary received medical device registration for infusion pumps and information collection systems [1] - Keda Li's subsidiary completed a capital increase, raising its registered capital from 200 million yuan to 400 million yuan [1] - Xingye Technology applied for a credit limit of 372 million yuan from Guangfa Bank [1] - Hengrui Medicine signed a collaboration agreement with GSK, involving a potential total payment of approximately 12 billion USD based on project milestones [1]

Core Insights - Hunan Xiangjiang New Area is recognized as the first national-level new area in Central China, showcasing high innovation and economic vitality, with a focus on optimizing the business environment and fostering entrepreneurship [1][2] Group 1: Business Environment and Services - The Xiangjiang New Area prioritizes optimizing the business environment as a key strategy for high-quality development, providing efficient services to new projects [2][4] - The area has implemented a "320" approval service reform, reducing the processing time for over 1,071 non-frequent items by more than 20% [4][5] - The administrative service bureau has provided comprehensive support for projects, exemplified by a 3 billion yuan investment project that saw an average approval time reduction of nearly 40% [2][4] Group 2: Financial Support and Innovation - Xiangjiang New Area has developed a financial service system that includes products like "Sci-Tech Loan" and "Zhaolian Easy Loan" to address financing challenges for small and micro enterprises [4][5] - The area launched the "Daily Luyuan" platform, the first equity financing platform for sci-tech enterprises in Hunan, enhancing access to capital for startups [4] - In 2025, the area plans to allocate 1 billion yuan for initiatives supporting university student entrepreneurship, with annual funding of 50 million yuan for specific programs [9] Group 3: Talent and Entrepreneurship - The Xiangjiang New Area is home to over 40 universities and has nurtured numerous entrepreneurial ventures, with significant financial support for student-led startups [6][9] - The area has established a comprehensive service system for innovation, covering the entire lifecycle from idea incubation to project acceleration and industrialization [8] - The region has attracted over 500 overseas-funded enterprises and a large number of returnee talents, contributing to a vibrant innovation ecosystem [1][12] Group 4: Industry Development - Since 2015, the Xiangjiang New Area has attracted over 2,000 biopharmaceutical companies, creating a comprehensive industrial cluster that includes traditional Chinese medicine and medical devices [13] - The area has seen significant growth in the number of enterprises, with 7,738 new companies established in the first quarter of this year, leading to a total of 164,120 enterprises [9]